submit to the journals

Endocrine Oncology Journal Articles, Videos And Insights

Endocrine Oncology:FEATURED Articles

flipper_slider

Endocrine Oncology: Latest Articles

Endocrine Oncology:FEATURED VIDEOS

Editor's choice

Dr Michael Lean (Chair of Human Nutrition [Medicine], University of Glasgow, Glasgow, UK) reviews the Diabetes Remission Clinical Trial (DiRECT). Weight loss is the most important thing patients can do to reduce glycated hemoglobin, reduce/eliminate comorbidities, and eventually gain diabetes remission. The DiRECT trial, funded by Diabetes UK, has been set up to help patients lose weight without bariatric surgery, and in turn become non-diabetic. Post-hoc analyses of the DiRECT trial have shown that almost 50% of patients can achieve remission of diabetes through weight loss, but the question remains, how do we identify these patients? Results showed there was no difference in males and females, older patients performed better than their younger counterparts, and certain medications hindered weight loss. Finally, Dr Lean highlights one of the main focuses of ADA 2018, which is drivers of disease progression, being high lipids and high insulin – both of which are caused by weight gain. Questions: 1. What was the background and rationale behind the Diabetes Remission Clinical Trial (DiRECT)? (0:14) 2. What were the findings of the post-hoc analysis presented at this meeting? (1:35) 3. What are the next steps in this area of research over the coming years? (3:08) 4. What are you highlights from this year’s ADA meeting? (4:15) Filmed at the American Diabetes Association (ADA) Annual Meeting, June 2018
Memorial Sloan-Kettering Cancer Center specialists in endocrinology, surgery, and radiology discuss the latest approaches to diagnosing and treating thyroid cancer, and reducing the risk of recurrence.

Endocrine Oncology:Latest Videos

Video List based on Category on Node Page

Latest Videos

Dr Michael Lean (Chair of Human Nutrition [Medicine], University of Glasgow, Glasgow, UK) reviews the Diabetes Remission Clinical Trial (DiRECT). Weight loss is the most important thing patients can do to reduce glycated hemoglobin, reduce/eliminate comorbidities, and eventually gain diabetes...
Dr. David Kooby, surgical oncologist at Winship Cancer Institute of Emory University, describes the surgical treatment options available to patients diagnosed with pancreatic cancer.
A Pituitary World News interview with esteemed pituitary neurological surgeon Dr. Manish Aghi at University of California, San Francisco on September 24, 2014.
Matthew Kulke, MD, of the Dana-Farber Cancer Institute explains why progressive free survival is a more appropriate outcome measure for clinical trials involving patients with neuroendocrine tumors.
Advancement of cancer genomics via cross-institutional collaboration, with specific reference to pancreatic cancer
Memorial Sloan-Kettering Cancer Center specialists in endocrinology, surgery, and radiology discuss the latest approaches to diagnosing and treating thyroid cancer, and reducing the risk of recurrence.

LATEST TWEETS

Conference Highlights